Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.
Borghetti P, Volpi G, Facheris G, Cossali G, Mataj E, La Mattina S, Singh N, Imbrescia J, Bonù ML, Tomasini D, Vitali P, Greco D, Bezzi M, Melotti F, Benvenuti M, Borghesi A, Grisanti S, Buglione di Monale E Bastia M. Borghetti P, et al. Among authors: imbrescia j. Front Oncol. 2023 Jul 4;13:1208204. doi: 10.3389/fonc.2023.1208204. eCollection 2023. Front Oncol. 2023. PMID: 37469420 Free PMC article.
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients.
Bonù ML, La Mattina S, Singh N, Toraci C, Spiazzi L, Terraneo F, Barbera F, Vitali P, Frassine F, Guerini A, Triggiani L, Tomasini D, Morelli V, Imbrescia J, Andreuccetti J, Frittoli B, Pittiani F, Grazioli L, Portolani N, Nicosia L, Albano D, Bertagna F, Magrini SM, Buglione M. Bonù ML, et al. Among authors: imbrescia j. Front Oncol. 2022 Oct 24;12:973223. doi: 10.3389/fonc.2022.973223. eCollection 2022. Front Oncol. 2022. PMID: 36353538 Free PMC article.
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC.
Borghetti P, Imbrescia J, Volpi G, Scotti V, Aquilano M, Bruni A, Franceschini D, Ursino S, Ciammella P, Piperno G, Taraborrelli M, Magrini SM. Borghetti P, et al. Among authors: imbrescia j. Radiat Oncol. 2022 Jul 16;17(1):124. doi: 10.1186/s13014-022-02084-5. Radiat Oncol. 2022. PMID: 35842660 Free PMC article.
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment.
Guerini AE, Tucci A, Alongi F, Mataj E, Belotti A, Borghetti P, Triggiani L, Pegurri L, Pedretti S, Bonù M, Tomasini D, Imbrescia J, Donofrio A, Facheris G, Singh N, Volpi G, Tomasi C, Magrini SM, Spiazzi L, Buglione M. Guerini AE, et al. Among authors: imbrescia j. Cancers (Basel). 2022 May 2;14(9):2273. doi: 10.3390/cancers14092273. Cancers (Basel). 2022. PMID: 35565401 Free PMC article.
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy.
Borghetti P, Toraci C, Imbrescia J, Volpi G, Lucchini S, Guerini AE, Magli A, Spiazzi L, Reginelli A, Cappabianca S, Magrini SM, Nardone V. Borghetti P, et al. Among authors: imbrescia j. Ann Nucl Med. 2021 Oct;35(10):1174-1176. doi: 10.1007/s12149-021-01662-z. Epub 2021 Jul 28. Ann Nucl Med. 2021. PMID: 34322785 Free PMC article. No abstract available.
Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin ice.
Buglione M, Spiazzi L, Guerini AE, Barbera F, Pasinetti N, Pegurri L, Triggiani L, Tomasini D, Greco D, Costantino G, Bragaglio A, Bonometti N, Liccioli M, Mascaro L; Radiation Oncology Department Staff; Alongi F, Magrini SM. Buglione M, et al. Radiat Oncol. 2020 Aug 10;15(1):191. doi: 10.1186/s13014-020-01631-2. Radiat Oncol. 2020. PMID: 32778174 Free PMC article.
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.
Guerini AE, Borghetti P, Filippi AR, Bonù ML, Tomasini D, Greco D, Imbrescia J, Volpi G, Triggiani L, Borghesi A, Maroldi R, Pasinetti N, Buglione M, Magrini SM. Guerini AE, et al. Among authors: imbrescia j. Clin Lung Cancer. 2020 Nov;21(6):e547-e550. doi: 10.1016/j.cllc.2020.05.027. Epub 2020 Jun 2. Clin Lung Cancer. 2020. PMID: 32527714 Free PMC article. No abstract available.